Back to AG ADAGE CAPITAL PARTNERS GP, L.L.C.

CRVOCRVO
6 quarters

Position history for AGADAGE CAPITAL PARTNERS GP, L.L.C.'s holdings in CERVOMED INC

No. Adage Capital Partners GP exited its CRVO (Cervomed) position in Q4 2024. Its Q3 2024 13F listed 28,600 shares worth $417,560. Adage Capital Partners GP first reported CRVO in Q3 2023 and held it in 5 quarterly 13F filings.

Final Value

$0

Final Shares

0

Total Value Change

-$920,983

Total Shares Change

-199,347

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2024-Q4
Latest
Exited
0
-100.0%
$00.0%$2.34
0
2024-Q3
Decreased
28,600
-28.6%
$417,5600.0%$14.60
0
2024-Q2
Decreased
40,033
-79.9%
$685,3650.0%$17.12
0
2024-Q1
Unchanged
199,347
0.0%
$4.6M0.0%$23.30
0
2023-Q4
Unchanged
199,347
0.0%
$1.5M0.0%$7.63
0
2023-Q3
New
199,347
-
$920,9830.0%$4.62
35

Other major holders of CRVO: RA CAPITAL MANAGEMENT, L.P., VANGUARD GROUP INC, BlackRock Finance, Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used